This Fruit Kills Diabetes and Stops Breast Cancer Cells from Growing and Spreading

Bitter melon is a fruit widely used in eastern cultures; the west has not such a wide knowledge of this fruit which is our shame. It has been traditionally used for centuries by the east for the treatment of fever, stomach cramps, hypertension, high cholesterol, piles, glaucoma, skin infections, and many other health conditions.

This fruit is high in protein, momordine, momorcharins, alkaloids, acids, glycoside, peptides, cucurbins, charantin, and cucurbitacins.
The included substances in better melon like charantin, cucurbitanoids, momordicin and oleanolic acids are accountable for the fruit’s hypoglycemic properties. Many recent studies have confirmed that this fruit is a viable hypoglycemia and cancer remedy.

Bitter Melon Impacts Breast Cancer

The University of Saint Louis carried out a study regarding the ability of bitter melon extract to hamper further development of breast cancer cells. This extract can activate a chain of events on a cellular level thus stopping breast cancer cells from spreading. The lead scientist of this study, have come to the conclusion:

“Bitter melon extract modulates several signal transduction pathways, which cause breast cancer cell death. This extract can be used as a dietary supplement for the prevention of breast cancer.”

Bitter melon can be consumed raw or included to healthy smoothies. Likewise, it is available as supplement in every health stores.

Bitter Melon and Diabetes

Two institutes the Garvan Institute of Medical Research and the Shanghai Institute of Materia Medica have come to the findings that this fruit is for sure a possible cure for diabetes. Bitter melon has in its content chemical substances which activate AMPK that incites movement of the glucose receptors to the surface of cells.

According to a report of the study: “More transporters on cells’ surfaces increase the uptake of glucose from circulation in the blood into tissues of the body, such as muscle, therefore reducing blood sugar level,”

The study was published in the journal of Ethnopharmacology where it was revealed that bitter melon had a modest hypoglycemic impact and significantly reduced fructosamine levels from the baseline in patients with type-2 diabetes who received 2,000 mg/day. Yet, the hypoglycemic effect of bitter melon was lower than metformin at 1,000 mg/day.